Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FRRH3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,330
Award facts
- Contract value 100% obligated
- $11,330.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,330.16 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 100-unit vials of BOTOX. This delivery order, issued December 12, 2025, with an ultimate completion date of January 6, 2026, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. DMS Pharmaceutical Group is the sole awardee with no identified subcontractors on this order.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded November 13, 2025, that positions the company as a critical regional pharmaceutical supplier for Department of Defense medical facilities worldwide. The PPV-G GEN V initiative is part of a broader $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to military healthcare operations. The delivery order reflects the company's established capability to supply specialized pharmaceutical products, including specialty medications and biologics, to support the diverse medical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FRRH3?
SPE2DR26FRRH3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FRRH3 worth?
The government has obligated $11,330 on SPE2DR26FRRH3.
Is contract SPE2DR26FRRH3 an order under another contract?
Yes. SPE2DR26FRRH3 is a delivery order under SPE2DR25D9238, an indefinite delivery contract.
Was contract SPE2DR26FRRH3 competed?
The extent of competition for SPE2DR26FRRH3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award